Evidence map›Paper›PMID 39379783›Full record

ArticleEJNMMI research2024

Heparin does not improve myocardial glucose metabolism suppression in [18 F]FDG PET/CT in patients with low β-hydroxybutyrate level.

Suvi Hartikainen, Ville Vepsäläinen, Tiina Laitinen, Marja Hedman, Tomi Laitinen, Tuomo Tompuri

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Suvi HartikainenDepartment of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital, Kuopio, Finland. suvi.hartikainen@pshyvinvointialue.fi.ORCID http://orcid.org/0000-0001-7718-5144
Ville VepsäläinenHeart Centre, Kuopio University Hospital, Kuopio, Finland.ORCID http://orcid.org/0000-0001-7712-2506
Tiina LaitinenDepartment of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital, Kuopio, Finland.ORCID http://orcid.org/0000-0002-3361-096X
Marja HedmanInstitute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.ORCID http://orcid.org/0000-0003-1318-8287
Tomi LaitinenDepartment of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital, Kuopio, Finland.ORCID http://orcid.org/0000-0003-3553-9957
Tuomo TompuriDepartment of Clinical Physiology, North Karelia Central Hospital, Joensuu, Finland.ORCID http://orcid.org/0000-0003-3748-7580

Funding

Itä-Suomen Yliopisto Itä-Suomen YliopistoKuopion Yliopistollinen Sairaala Kuopion Yliopistollinen SairaalaSuomen Lääketieteen Säätiö 6145Sydäntutkimussäätiö 230027
6 · The paper itself

Abstract

backgroundInadequate myocardial glucose metabolism suppression (GMS) can hamper interpretation of cardiac [

results155 patients (82 male) had followed a high-fat, low-carbohydrate diet and fasted for at least twelve hours. For the first 63 patients, BHB was measured, but it was not used to guide premedication. For the subsequent 92 patients, heparin 50 IU/kg was injected intravenously 15-20 min before [

conclusionsWhile high BHB predicts adequate GMS, unfractionated heparin does not improve GMS in patients with low BHB.

Indexed as

Beta-hydroxybutyrateBHBFDG-PETGlucose metabolismHeparinMyocardial inflammationMyocardium

Identifiers

PMID39379783
PMCPMC11461714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.